Results 101 to 110 of about 20,481 (152)

EFFICACY OF COLISTIN AND NON-COLISTIN MONOTHERAPIES IN MULTI-DRUG RESISTANT ACINETOBACTER BAUMANNII BACTEREMIA/SEPSIS

, 2014
Objective: This retrospective study aimed to investigate the efficacies of colistin and non-colistin monotherapies in multi-drug resistant Acinetobacter baumannii bacteremia (MDR-AB)
Kilic, Aysegul Ulu, Engin, Aynur, GUCLUI, Ertugrul, GUVEN, Tumer, Aslan, Turan, Gonen, Ibak, Alp, Emine, Sezak, Nurbanu, Turker, N., Yilmaz, Hava, AGALAR, Canan, Hosoglu, Salih, Karabay, Oguz, OZTOPRAK, Nefise, Bekiroglu, Nural, CESUR, Salim, ENGIN, Derya Ozturk, Balkan, Ilker Inanc, DURDU, Bulent, ALICI, Ozlem, Celik, Aygul Dogan, Ozer, Serdal, ALTA, F. Aybala, HATIPOGLU, Cigdem Ataman, Duygu, Fazilet, Karahocagil, Mustafa, ORMEN, Bahar, TURHAN, Vedat, Ozdemir, Davut, BATIREL, Ayse, Arslan, Ferhat, ALTIN, N., Dogan, Mustafa, Akalin, Serife   +33 more
core   +3 more sources

Alteration in the Morphological and Transcriptomic Profiles of Acinetobacter baumannii after Exposure to Colistin

Microorganisms
Acinetobacter baumannii is often highly resistant to multiple antimicrobials, posing a risk of treatment failure, and colistin is a “last resort” for treatment of the bacterial infection. However, colistin resistance is easily developed when the bacteria
Eun-Jeong Yoon, Jun Won Mo, Jee-woong Kim, Min Chul Jeong, Jung Sik Yoo   +4 more
doaj   +1 more source

Azomycin Orchestrate Colistin-Resistant Enterobacter cloacae Complex’s Colistin Resistance Reversal In Vitro and In Vivo

The Enterobacter cloacae complex (ECC) is a group of nosocomial pathogens that pose a challenge in clinical treatment due to its intrinsic resistance and the ability to rapidly acquire resistance. Colistin was reconsidered as a last-resort antibiotic for
Yijia Han (16614747), Jianming Cao (4380778), Panjie Hu (3902923), Zhexiao Ma (17878730), Mo Shen (350564), Deyi Zhao (17878727), Huanchang Chen (17345703), Weiliang Zeng (4252582), Tieli Zhou (129625)   +8 more
core   +1 more source

Second-Generation Tryptamine Derivatives Potently Sensitize Colistin Resistant Bacteria to Colistin

, 2019
Antibiotic resistance has significantly increased since the beginning of the 21st century. Currently, the polymyxin colistin is typically viewed as the antibiotic of last resort for the treatment of multidrug resistant Gram-negative bacterial infections.
Christian Melander (1751038), William T. Barker, Beverly H. Koller (296631), Beverly H. Koller, Veronica B. Hubble, William T. Barker (5310224), Roberta J. Melander, Bradley M. Minrovic (6597359), Veronica B. Hubble (6030278), Roberta J. Melander (1751032), Leigh A. Jania (6597362), Christian Melander, Bradley M. Minrovic, Leigh A. Jania   +13 more
core   +1 more source

Resensitization to colistin results in rapid and stable recovery of adherence, serum resistance and ompW in Acinetobacter baumannii.

PLoS ONE
BackgroundColistin resistance in Acinetobacter baumannii is an emerging problem that limits antimicrobial therapy options.Materials & methodsWe isolated two pairs of colistin susceptible and colistin-resistant A.
Jale Boral, Cansel Vatansever, Gulin Ozcan, Siran Keske, Sirin Menekse, Mehmet Gonen, Fusun Can   +6 more
doaj   +1 more source

Characterization Of Chromosome-Mediated Colistin Resistance In Escherichia coli Isolates From Livestock In Korea

Infection and Drug Resistance, 2019
Shukho Kim,1 Jung Hwa Woo,1 Nayeong Kim,1 Mi Hyun Kim,1 Se Yeon Kim,1 Joo Hee Son,1 Dong Chan Moon,2 Suk-Kyung Lim,2 Minsang Shin,1 Je Chul Lee1 1Department of Microbiology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea ...
Kim S, Woo JH, Kim N, Kim MH, Kim SY, Son JH, Moon DC, Lim SK, Shin M, Lee JC   +9 more
doaj  

Efficacy of Endolysin LysAB1245 Combined with Colistin as Adjunctive Therapy Against Colistin-Resistant Gram-Negative Bacteria

Background: Colistin resistance among Gram-negative nosocomial pathogens is an increasing concern. The bacteriophage-encoded lytic enzyme endolysin LysAB1245, which targets bacterial peptidoglycan, was evaluated as a potential antibacterial agent in ...
Potjanee Srimanote, Chusri, Sarunyou, Sarunyou Chusri, Rosesathorn Soontarach, Supayang Piyawan Voravuthikunchai, Soontarach, Rosesathorn, Voravuthikunchai, Supayang Piyawan, Srimanote, Potjanee   +7 more
core   +1 more source

Management with colistin

Indian Journal of Critical Care Medicine, 2010
openaire   +2 more sources

The Potentiation Activity of Azithromycin in Combination with Colistin or Levofloxacin Against Pseudomonas aeruginosa Biofilm Infection [PDF]

Yuhang Wang,1,* Chunsun Li,2,* Huan Zhang,1 Yulong Chi,1 Yun Cai1 1Center of Medicine Clinical Research, Department of Pharmacy, Medical Supplies Center of PLA General Hospital, Beijing, People’s Republic of China; 2Laboratory of Department of ...
Li C, Zhang H, Cai Y, Wang Y, Chi Y
core  

Colistin rapid NP test for detection of colistin-resistance in colistin-resistant enterobacterales

Medical Journal Armed Forces India
Kleebayoon, Amnuay, Wiwanitkit, Viroj
openaire   +3 more sources